[Clinical value of immunologic studies in patients with bladder tumors].
By means of mathematical calculations the authors tried to find correlations between the clinical and histological stages of vesical tumours and the results of immunological tests. Density calculation showed what parameters follow the degrees of malignity. Moreover the significance of the chain and basic proportional factors of the parameters calculated for diagnosis and follow-up is pointed out.
D000912:Antibodies, Neoplasm / Q000032:analysis; D001609:Beta-Globulins / Q000032:analysis; D002570:Ceruloplasmin / Q000032:analysis; D006242:Haptoglobins / Q000032:analysis; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D008213:Lymphocyte Activation; D009367:Neoplasm Staging; D009961:Orosomucoid / Q000032:analysis; D010212:Papilloma / Q000276:immunology* / Q000473:pathology; D001749:Urinary Bladder Neoplasms / Q000276:immunology* / Q000473:pathology; D000515:alpha 1-Antitrypsin / Q000032:analysis; D000511:alpha-Macroglobulins / Q000032:analysis
D000912:Antibodies, Neoplasm; D001609:Beta-Globulins; D006242:Haptoglobins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D009961:Orosomucoid; D000515:alpha 1-Antitrypsin; D000511:alpha-Macroglobulins; C029590:beta-1C-globulin; D002570:Ceruloplasmin
Der klinische Wert immunologischer Untersuchungen bei Patienten mit Blasentumoren.